POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond

Bartholomeus Rombaut; Bert Thys; Armando M. De Palma; Johan Neyts; Koen Andries; Raphael Vrijsen

POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond

Bartholomeus Rombaut
, Bert Thys
, Armando M. De Palma
, Johan Neyts
, Koen Andries
, Raphael Vrijsen

Research output: Chapter in Book/Report/Conference proceeding › Conference paper

Abstract

In this study the antiviral activity of a panel of eighteen out of two hundred and forty pyridazinamine analogues was evaluated against the Sabin strains of the three poliovirus types.

Original language	English
Title of host publication	International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)
Publication status	Published - 2008
Event	Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet - Stockholm, Sweden Duration: 21 Sept 2009 → 25 Sept 2009

Publication series

Name	International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)

Conference

Conference	Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet
Country/Territory	Sweden
City	Stockholm
Period	21/09/09 → 25/09/09

Keywords

R75761
antiviral drugs
poliomyelitis
eradication

Handle.net

Persistent link

Cite this

Rombaut, B., Thys, B., De Palma, A. M., Neyts, J., Andries, K., & Vrijsen, R. (2008). POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond. In International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august) (International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)).

Rombaut, Bartholomeus ; Thys, Bert ; De Palma, Armando M. et al. / POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond. International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august). 2008. (International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)).

@inproceedings{6efb5dd7fe784ebe97215678e41e544f,

title = "POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond",

abstract = "In this study the antiviral activity of a panel of eighteen out of two hundred and forty pyridazinamine analogues was evaluated against the Sabin strains of the three poliovirus types.",

keywords = "R75761, antiviral drugs, poliomyelitis, eradication",

author = "Bartholomeus Rombaut and Bert Thys and \{De Palma\}, \{Armando M.\} and Johan Neyts and Koen Andries and Raphael Vrijsen",

year = "2008",

language = "English",

series = "International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)",

booktitle = "International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)",

note = "Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet ; Conference date: 21-09-2009 Through 25-09-2009",

}

Rombaut, B, Thys, B, De Palma, AM, Neyts, J, Andries, K & Vrijsen, R 2008, POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond. in International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august). International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august), Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet, Stockholm, Sweden, 21/09/09.

POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond. / Rombaut, Bartholomeus; Thys, Bert; De Palma, Armando M. et al.
International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august). 2008. (International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)).

Research output: Chapter in Book/Report/Conference proceeding › Conference paper

TY - GEN

T1 - POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond

AU - Rombaut, Bartholomeus

AU - Thys, Bert

AU - De Palma, Armando M.

AU - Neyts, Johan

AU - Andries, Koen

AU - Vrijsen, Raphael

PY - 2008

Y1 - 2008

N2 - In this study the antiviral activity of a panel of eighteen out of two hundred and forty pyridazinamine analogues was evaluated against the Sabin strains of the three poliovirus types.

AB - In this study the antiviral activity of a panel of eighteen out of two hundred and forty pyridazinamine analogues was evaluated against the Sabin strains of the three poliovirus types.

KW - R75761

KW - antiviral drugs

KW - poliomyelitis

KW - eradication

M3 - Conference paper

T3 - International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)

BT - International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)

T2 - Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet

Y2 - 21 September 2009 through 25 September 2009

ER -

Rombaut B, Thys B, De Palma AM, Neyts J, Andries K, Vrijsen R. POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond. In International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august). 2008. (International Union of Microbiological Sciences - meeting of the three divisions, Istanbul (5-15 august)).

POSTER : R75761, a lead compound for the development of antiviral drugs used during the end game of poliomyelitis eradication and beyond

Abstract

Publication series

Conference

Keywords

Handle.net

Fingerprint

Cite this